Immunovia appoints Philipp Mathieu as Acting CEO

/PRNewswire/ -- Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a...

Related Keywords

Sweden ,United States ,Stockholm ,Massachusetts ,Carl Borrebaeck ,Philipp Mathieu ,Immunovia Inc ,Corporate Communications ,Department Of Immuntechnology At Lund University ,Health Cancer Center ,Director Investor Relations ,Lund University ,Cancer Center ,Immunovia Ab ,